[Medical adherence as the basis for effective therapy - current state of the art]

The study was to assess the importance of the problem of medical adherence (MA) among therapists in St. Petersburg (2021).

The study involved 96 doctors of various therapeutic specialties (neurologists, therapists and rheumatologists), who were asked to respond to an original questionnaire concerning MA, that was designed in neurology department of Military Medical academy n.a. S.M. Kirov, St. Petersburg It was found that, according to experts, the main negative factors that significantly decreases MA are the high cost of the drug (40.1%) and polypharmacy (22.1%); the main property of the drug associated with high MA is the convenience of taking it - once a day (51.1%). Such drugs include, for example, a new form of the muscle relaxant tolperisone hydrochloride prolonged release 450 mg.

According to experts, the main negative factors that significantly reduce MA are the high cost of the drug (40.1%) and polypharmacy (22.1%); the main property of the drug associated with high MA on the part of patients is the convenience of its administration - 1 once a day (51.1%). Such drugs include, for example, a new form of release of the muscle relaxant tolperisone hydrochloride prolonged release 450 mg.

A systematic approach is required to improve MA, carried out both at the state level (changing public consciousness, financing systems, etc.) and in tandem doctor-patient (moving away from paternalistic medicine, prescribing depot forms of drugs, etc.).